Resultados da pesquisa - (((esmo OR eso) open) or (tests open))

Pesquisas alternativas:
esmo » esto (Expandir a Pesquisa), ecmo (Expandir a Pesquisa), esko (Expandir a Pesquisa)
eso » esto (Expandir a Pesquisa), esos (Expandir a Pesquisa)

1

Endoscopic Saphenous harvesting with an Open CO2 System (ESOS) trial for coronary artery bypass grafting surgery: study protocol for a randomized controlled trial

Endoscopic Saphenous harvesting with an Open CO2 System (ESOS) trial for coronary artery bypass...

Por Campanella, Antonio, Bergamasco, Laura, Macri, Luigia, Asioli, Sofia, Devotini, Roger, Scipioni, Serenella, Barbaro, Silvana, Rispoli, Pietro, Rinaldi, Mauro
Publicado em 2011

“... is increasingly being investigated in order to reduce the morbidity associated with conventional open vein...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

2

Differential research impact in cancer practice guidelines’ evidence base: lessons from ESMO, NICE and SIGN

Differential research impact in cancer practice guidelines’ evidence base: lessons from ESMO, NICE and SIGN

Por Pallari, Elena, Fox, Anthony W, Lewison, Grant
Publicado no ESMO Open (2018)

“... SPSS (V.24.0) for statistical tests. RESULTS: ESMO CPGs mostly cited research from Western Europe...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

3

Updating of the role of verbal analogies and their predictive capacity on final ESO exam

Updating of the role of verbal analogies and their predictive capacity on final ESO exam

Por Gregorio Pérez Bonet
Publicado em 2018-12-01

Assuntos: “...evaluación final eso...”
Obter o texto integral

Artigo

4

NY-ESO-1 expression in sarcomas: A diagnostic marker and immunotherapy target

NY-ESO-1 expression in sarcomas: A diagnostic marker and immunotherapy target

Por Lai, Jin-Ping, Rosenberg, Avi Z., Miettinen, Markku M., Lee, Chyi-Chia R.
Publicado em 2012

“... have been obtained in clinical trials testing NY-ESO-1-targeted immunotherapy in subsets of melanoma...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

5

NY-ESO-1 as a potential immunotherapeutic target in renal cell carcinoma

NY-ESO-1 as a potential immunotherapeutic target in renal cell carcinoma

Por Giesen, Eva, Jilaveanu, Lucia B., Parisi, Fabio, Kluger, Yuval, Camp, Robert L., Kluger, Harriet M.
Publicado em 2014

“... purpose was to determine expression of the cancer testes antigen NY-ESO-1 in renal cell carcinoma (RCC...”
Obter o texto integral
Obter o texto integral

Artigo

6

Electroactive Shape Memory Property of a Cu-decorated CNT Dispersed PLA/ESO Nanocomposite

Electroactive Shape Memory Property of a Cu-decorated CNT Dispersed PLA/ESO Nanocomposite

Por Alam, Javed, Khan, Aslam, Alam, Manawwer, Mohan, Raja
Publicado no Materials (Basel) (2015)

“... (PLA)/epoxidized soybean oil (ESO) blend matrix. The shape memory effect (SME) induced by an electrical...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

7

NY-ESO-1- and survivin-specific T-cell responses in the peripheral blood from patients with glioma

NY-ESO-1- and survivin-specific T-cell responses in the peripheral blood from patients with glioma

Por Liu, Zhenjiang, Poiret, Thomas, Persson, Oscar, Meng, Qingda, Rane, Lalit, Bartek, Jiri, Karbach, Julia, Altmannsberger, Hans-Michael, Illies, Christopher, Luo, Xiaohua, Harvey-Peredo, Inti, Jäger, Elke, Dodoo, Ernest, Maeurer, Markus
Publicado no Cancer Immunol Immunother (2017)

“... cellular therapies. Immunohistochemistry was used to test the survivin (n = 40 samples) and NY-ESO-1 (n...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

8

Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS)

Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS)

Por Herrick, Ariane L, Pan, Xiaoyan, Peytrignet, Sébastien, Lunt, Mark, Hesselstrand, Roger, Mouthon, Luc, Silman, Alan, Brown, Edith, Czirják, László, Distler, Jörg H W, Distler, Oliver, Fligelstone, Kim, Gregory, William J, Ochiel, Rachel, Vonk, Madelon, Ancuţa, Codrina, Ong, Voon H, Farge, Dominique, Hudson, Marie, Matucci-Cerinic, Marco, Balbir-Gurman, Alexandra, Midtvedt, Øyvind, Jordan, Alison C, Jobanputra, Paresh, Stevens, Wendy, Moinzadeh, Pia, Hall, Frances C, Agard, Christian, Anderson, Marina E, Diot, Elisabeth, Madhok, Rajan, Akil, Mohammed, Buch, Maya H, Chung, Lorinda, Damjanov, Nemanja, Gunawardena, Harsha, Lanyon, Peter, Ahmad, Yasmeen, Chakravarty, Kuntal, Jacobsen, Søren, MacGregor, Alexander J, McHugh, Neil, Müller-Ladner, Ulf, Riemekasten, Gabriela, Becker, Michael, Roddy, Janet, Carreira, Patricia E, Fauchais, Anne Laure, Hachulla, Eric, Hamilton, Jennifer, İnanç, Murat, McLaren, John S, van Laar, Jacob M, Pathare, Sanjay, Proudman, Susannah, Rudin, Anna, Sahhar, Joanne, Coppere, Brigitte, Serratrice, Christine, Sheeran, Tom, Veale, Douglas J, Grange, Claire, Trad, Georges-Selim, Denton, Christopher P
Publicado no Ann Rheum Dis (2017)

“... probability of treatment (IPT) weights. As a secondary outcome, an IPT-weighted Cox model was used to test...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

9

A Cancer Vaccine Induces Expansion of NY-ESO-1-Specific Regulatory T Cells in Patients with Advanced Melanoma

A Cancer Vaccine Induces Expansion of NY-ESO-1-Specific Regulatory T Cells in Patients with Advanced Melanoma

Por Ebert, Lisa M., MacRaild, Sarah E., Zanker, Damien, Davis, Ian D., Cebon, Jonathan, Chen, Weisan
Publicado em 2012

“... for Treg specific to the NY-ESO-1 tumor antigen in melanoma patients treated with the NY-ESO-1/ISCOMATRIX...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

10

Performance of standard procedures in detection of EGFR mutations in daily practice in advanced NSCLC patients selected according to the ESMO guideline: a large Caucasian cohort study

Performance of standard procedures in detection of EGFR mutations in daily practice in advanced NSCLC patients selected according to the ESMO guideline: a large Caucasian cohort study

Por Hantson, Inge, Dooms, Christophe, Verbeken, Eric, Vandenberghe, Peter, Vliegen, Liesbet, Roskams, Tania, Borght, Sara Vander, Nackaerts, Kris, Wauters, Isabelle, Vansteenkiste, Johan
Publicado em 2014

“...BACKGROUND: ESMO consensus recommends EGFR mutation testing in never/former light smokers (<15 pack...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

11

Trypanosoma cruzi Adjuvants Potentiate T Cell-Mediated Immunity Induced by a NY-ESO-1 Based Antitumor Vaccine

... Trypanosoma cruzi Adjuvants Potentiate T Cell-Mediated Immunity Induced by a NY-ESO-1 Based...

Por Junqueira, Caroline, Guerrero, Ana Tereza, Galvão-Filho, Bruno, Andrade, Warrison A., Salgado, Ana Paula C., Cunha, Thiago M., Ropert, Catherine, Campos, Marco Antônio, Penido, Marcus L. O., Mendonça-Previato, Lúcia, Previato, José Oswaldo, Ritter, Gerd, Cunha, Fernando Q., Gazzinelli, Ricardo T.
Publicado em 2012

“..., we tested the T. cruzi derived TLR agonists as immunological adjuvants in an antitumor vaccine...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

12

Decitabine immunosensitizes human gliomas to NY-ESO-1 specific T lymphocyte targeting through the Fas/Fas Ligand pathway

Decitabine immunosensitizes human gliomas to NY-ESO-1 specific T lymphocyte targeting through the Fas/Fas Ligand pathway

Por Konkankit, Veerauo V, Kim, Won, Koya, Richard C, Eskin, Ascia, Dam, Mai-Anh, Nelson, Stanley, Ribas, Antoni, Liau, Linda M, Prins, Robert M
Publicado em 2011

“... characterized cancer testes antigens. The upregulation of NY-ESO-1 made these tumors susceptible to NY-ESO-1...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

13

Tetramer guided, cell sorter assisted production of clinical grade autologous NY-ESO-1 specific CD8(+) T cells

Tetramer guided, cell sorter assisted production of clinical grade autologous NY-ESO-1 specific CD8(+) T cells

Por Pollack, Seth M, Jones, Robin L, Farrar, Erik A, Lai, Ivy P, Lee, Sylvia M, Cao, Jianhong, Pillarisetty, Venu G, Hoch, Benjamin L, Gullett, Ashley, Bleakley, Marie, Conrad, Ernest U, Eary, Janet F, Shibuya, Kendall C, Warren, Edus H, Carstens, Jason N, Heimfeld, Shelly, Riddell, Stanley R, Yee, Cassian
Publicado em 2014

“... but the very low frequency of T cells recognizing commonly expressed antigens such as NY-ESO-1 limit...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

14

Bi-specific TCR-anti CD3 redirected T-cell targeting of NY-ESO-1- and LAGE-1-positive tumors

Bi-specific TCR-anti CD3 redirected T-cell targeting of NY-ESO-1- and LAGE-1-positive tumors

Por McCormack, Emmet, Adams, Katherine J., Hassan, Namir J., Kotian, Akhil, Lissin, Nikolai M., Sami, Malkit, Mujić, Maja, Osdal, Tereza, Gjertsen, Bjørn Tore, Baker, Deborah, Powlesland, Alex S., Aleksic, Milos, Vuidepot, Annelise, Morteau, Olivier, Sutton, Deborah H., June, Carl H., Kalos, Michael, Ashfield, Rebecca, Jakobsen, Bent K.
Publicado em 2012

“...NY-ESO-1 and LAGE-1 are cancer testis antigens with an ideal profile for tumor immunotherapy...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

15

Promoter hypomethylation of NY-ESO-1, association with clinicopathological features and PD-L1 expression in non-small cell lung cancer

Promoter hypomethylation of NY-ESO-1, association with clinicopathological features and PD-L1 expression in non-small cell lung cancer

Por Chüeh, Anderly C., Liew, Mun-Sem, Russell, Prudence A., Walkiewicz, Marzena, Jayachandran, Aparna, Starmans, Maud H.W., Boutros, Paul C., Wright, Gavin, Barnett, Stephen A, Mariadason, John M., John, Thomas
Publicado no Oncotarget (2017)

“... to testes but with aberrant expression in up to 30% of non-small cell lung cancers (NSCLCs). Regulation...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

16

Integrated NY-ESO-1 antibody and CD8(+) T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab

Integrated NY-ESO-1 antibody and CD8(+) T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab

Por Yuan, Jianda, Adamow, Matthew, Ginsberg, Brian A., Rasalan, Teresa S., Ritter, Erika, Gallardo, Humilidad F., Xu, Yinyan, Pogoriler, Evelina, Terzulli, Stephanie L., Kuk, Deborah, Panageas, Katherine S., Ritter, Gerd, Sznol, Mario, Halaban, Ruth, Jungbluth, Achim A., Allison, James P., Old, Lloyd J., Wolchok, Jedd D., Gnjatic, Sacha
Publicado em 2011

“..., relative risk = 1.8, two-tailed Fisher test). To understand why some patients with NY-ESO-1 antibody failed...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

17

Bee Venom Phospholipase A2, a Good “Chauffeur” for Delivering Tumor Antigen to the MHC I and MHC II Peptide-Loading Compartments of the Dendritic Cells: The Case of NY-ESO-1

Bee Venom Phospholipase A2, a Good “Chauffeur” for Delivering Tumor Antigen to the MHC I and MHC II Peptide-Loading Compartments of the Dendritic Cells: The Case of NY-ESO-1

Por Almunia, Christine, Bretaudeau, Marie, Held, Gerhard, Babon, Aurélie, Marchetti, Charles, Castelli, Florence Anne, Ménez, André, Maillere, Bernard, Gillet, Daniel
Publicado em 2013

“... vaccines. To confirm this feature, in this study the fusion protein PNY, composed of NY-ESO-1(NY(s)) fused...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

18

Clinical validation of an autoantibody test for lung cancer

Clinical validation of an autoantibody test for lung cancer

Por Boyle, P., Chapman, C. J., Holdenrieder, S., Murray, A., Robertson, C., Wood, W. C., Maddison, P., Healey, G., Fairley, G. H., Barnes, A. C., Robertson, J. F. R.
Publicado em 2011

“..., NY-ESO-1, CAGE, GBU4-5, Annexin 1 and SOX2). Assay sensitivity was tested in relation to demographic...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

19

DNA Mismatch Repair Protein Immunohistochemistry and MLH1 Promotor Methylation Testing for Practical Molecular Classification and the Prediction of Prognosis in Endometrial Cancer

DNA Mismatch Repair Protein Immunohistochemistry and MLH1 Promotor Methylation Testing...

Por Kim, Jisup, Kong, Jin Kyoung, Yang, Wookyeom, Cho, Hanbyoul, Chay, Doo Byung, Lee, Bang Hyun, Cho, Seong Jin, Hong, Soonwon, Kim, Jae-Hoon
Publicado no Cancers (Basel) (2018)

“... by immunohistochemistry (IHC), followed by an MLH1 methylation test. Patients were classified into MMR deficiency...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

20

Evaluación de una intervención educativa para la alfabetización en datos mediante el uso del método científico y el aprendizaje situado / Assessment of an educational intervention for data literacy using scientific method and situated learning

Evaluación de una intervención educativa para la alfabetización en datos mediante el uso del método científico y el aprendizaje situado / Assessment of an educational intervention...

Por Alejandro CARBONELL-ALCOCER, Manuel GERTRUDIX-BARRIO
Publicado em 2019-07-01

Assuntos: “...open data...”
Obter o texto integral

Artigo

1
2
3
4
5
Seguinte
[5]